ADH1C Human

Alcohol Dehydrogenase 1C Human Recombinant
Shipped with Ice Packs
In Stock

Description

Molecular Identity and Structure

ADH1C, also termed class I alcohol dehydrogenase gamma subunit, is a zinc-containing enzyme (molecular weight: ~40.6 kDa) composed of 375 amino acids . It forms homo- or heterodimers with other class I subunits (α, β) and operates via a catalytic zinc ion coordinated by residues Cys-46, Cys-174, and His-67 . Key structural features include:

  • Active Site: Binds ethanol via zinc and facilitates hydride transfer to NAD⁺, producing acetaldehyde and NADH .

  • Structural Zinc Site: Stabilizes the protein through cysteine ligands (Cys97, Cys100, Cys103, Cys111) .

Functional Roles

ADH1C catalyzes the oxidation of diverse substrates:

SubstrateProductPhysiological Role
EthanolAcetaldehydeDetoxification of ingested alcohol
RetinolRetinaldehydeVitamin A metabolism
Lipid peroxidation productsAldehydesMitigation of oxidative stress

Its high ethanol oxidation capacity makes it pivotal in hepatic and gastric ethanol catabolism .

Genetic Polymorphisms and Disease Associations

The ADH1C Ile350Val (rs698) polymorphism alters enzyme activity and disease susceptibility:

Key Findings:

  • Alcohol Dependence (AD):

    • The ADH1C Ile allele (high-activity variant) reduces AD risk (OR = 1.51 for Val vs. Ile) .

    • Strongest protective effects observed in Asians (OR = 2.14) .

  • Cancer:

    • Downregulated ADH1C correlates with poor colorectal cancer (CRC) prognosis (HR = 1.8, p < 0.05) .

    • ADH1C Ile linked to reduced gastric and oral cancer risk .

  • Neurodegeneration:

    • ADH1C rs2241894 TT genotype associated with lower Alzheimer’s disease risk in Taiwanese women (OR = 0.25) .

Meta-Analysis Data (rs698) :

PopulationOdds Ratio (Val vs. Ile)P-value
Asian2.14 (1.89–2.43)4×10⁻³³
European1.31 (1.12–1.53)0.001

Clinical and Diagnostic Implications

  • Alcohol-Related Disorders: High-activity ADH1C Ile accelerates acetaldehyde accumulation, causing aversive reactions (flushing, nausea) and lowering alcoholism risk .

  • Cancer Biomarker: Reduced ADH1C expression in CRC tissues predicts worse survival (log-rank p = 0.009) .

  • Therapeutic Targets: ADH1C inhibition could modulate retinoic acid signaling, relevant for cancer therapy .

Research Tools and Applications

Recombinant ADH1C (produced in Sf9 cells) is utilized for:

  • Enzyme Kinetics: Studying ethanol metabolism and inhibitor screening .

  • Structural Studies: Resolving catalytic mechanisms via crystallography .

PropertyDetail
Purity>95% (SDS-PAGE)
Storage-20°C in PBS + 10% glycerol
Molecular Weight40.6 kDa

Unresolved Questions and Future Directions

  • Gene-Environment Interactions: How do lifestyle factors modulate ADH1C’s role in cancer?

  • Haplotype Effects: Linkage disequilibrium with ADH1B complicates allele-specific contributions .

  • Therapeutic Potential: Can ADH1C modulators treat alcohol use disorder or retinol-deficient diseases?

Product Specs

Introduction
ADH1C, a member of the zinc-containing alcohol dehydrogenase family, plays a crucial role in metabolizing a wide range of substrates including ethanol, retinol, aliphatic alcohols, hydroxysteroids, and lipid peroxidation products. This enzyme exhibits monomorphic behavior and is particularly vital in fetal and infant livers. However, its activity decreases during gestation and remains relatively low in adulthood.
Description
Recombinant human ADH1C, expressed in E. coli, is a single polypeptide chain comprising 399 amino acids (1-375) with a molecular weight of 42.4 kDa. This protein features a 24 amino acid His-tag at the N-terminus and undergoes purification using proprietary chromatographic methods.
Physical Appearance
A sterile, colorless solution free from particulate matter.
Formulation
The ADH1C solution is provided at a concentration of 0.5 mg/ml and is formulated in a buffer consisting of 20 mM Tris-HCl (pH 8.0), 0.2 M NaCl, 2 mM DTT, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the solution should be kept at 4°C. For longer storage periods, it is recommended to store the solution frozen at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is advisable for long-term storage. Avoid repeated freeze-thaw cycles to maintain product integrity.
Purity
The purity of ADH1C is determined to be greater than 90% as assessed by SDS-PAGE analysis.
Synonyms
Alcohol dehydrogenase 1C (class I) gamma polypeptide, Alcohol dehydrogenase subunit gamma, alcohol dehydrogenase 3 (class I) gamma polypeptide, ADH gamma subunit, aldehyde reductase, ADH3, EC 1.1.1.1, EC 1.1.1.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMSTAGK VIKCKAAVLW ELKKPFSIEE VEVAPPKAHE VRIKMVAAGI CRSDEHVVSG NLVTPLPVIL GHEAAGIVES VGEGVTTVKP GDKVIPLFTP QCGKCRICKN PESNYCLKND LGNPRGTLQD GTRRFTCSGK PIHHFVGVST FSQYTVVDEN AVAKIDAASP LEKVCLIGCG FSTGYGSAVK VAKVTPGSTC AVFGLGGVGL SVVMGCKAAG AARIIAVDIN KDKFAKAKEL GATECINPQD YKKPIQEVLK EMTDGGVDFS FEVIGRLDTM MASLLCCHEA CGTSVIVGVP PDSQNLSINP MLLLTGRTWK GAIFGGFKSK ESVPKLVADF MAKKFSLDAL ITNILPFEKI NEGFDLLRSG KSIRTVLTF.

Q&A

What is the ADH1C gene and what is its function in human metabolism?

ADH1C (formerly known as ADH3) encodes the gamma subunit of class I alcohol dehydrogenase, which plays a fundamental role in the oxidative catabolism of various substrates. The enzyme metabolizes ethanol into acetaldehyde, which is subsequently converted to acetate by aldehyde dehydrogenase 2 (ALDH2). Beyond ethanol metabolism, ADH1C is involved in the metabolism of retinol, other aliphatic alcohols, hydroxysteroids, and lipid peroxidation products . The gene is located on chromosome 4q21-q23, adjacent to ADH1B and within a gene cluster that includes alcohol dehydrogenase subunits 6, 1A, 1B, 1C, and 7 .

The enzyme's role in ethanol metabolism is particularly significant as it affects the rate at which alcohol is converted to acetaldehyde, potentially influencing drinking behavior and risk for alcohol-related disorders through variations in metabolic efficiency .

What are the major polymorphisms in the ADH1C gene?

The most extensively studied polymorphism in ADH1C is rs698 (Ile350Val in exon 8), formerly known as ADH1C*1/*2. The common form of this single nucleotide polymorphism is 350Val (G or *2), while the alternative allele 350Ile (A or *1) encodes a highly active allozyme . This allozyme can alter ethanol metabolism rates and has been associated with reduced genetic susceptibility to alcohol dependence .

Additional polymorphisms exist within the ADH1C gene and nearby genes within the strong linkage disequilibrium block, particularly nonsynonymous SNPs that may affect enzyme function. These variations occur within a complex haplotype structure that includes multiple ADH genes (ADH6, ADH1A, ADH1B, ADH1C, and ADH7), with the first four genes showing strong linkage disequilibrium .

How do ADH1C polymorphisms affect enzyme activity?

The ADH1C Ile350Val polymorphism significantly impacts enzyme activity. The ADH1C1 (350Ile) allele encodes a more active form of the enzyme that metabolizes alcohol at a faster rate compared to the ADH1C2 (350Val) variant .

In practical terms, carriers of the ADH1C1 allele convert ethanol to acetaldehyde more efficiently. This higher enzymatic activity can lead to more rapid accumulation of acetaldehyde following alcohol consumption, potentially resulting in adverse physiological responses that may deter excessive drinking . Conversely, the ancestor phenotype ADH1C1 is more active than ADH1C*2, which exhibits reduced enzymatic activity .

What statistical approaches are recommended for meta-analysis of ADH1C polymorphism studies?

Genotypic analyses should be carried out under both dominant ((ValVal + ValIle) vs. IleIle) and recessive (ValVal vs. (ValIle + IleIle)) models to fully capture potential genetic effects . For heterogeneity assessment, Cochran's Q statistic and the I² statistic are essential, with I² values of 25%, 50%, and 75% considered as low, moderate, and high heterogeneity, respectively .

Different combinations of ethnic populations and alcohol-related medical conditions should be analyzed separately to account for population stratification effects. Retrospective analysis can help identify potential publication year effects on results .

How does linkage disequilibrium with other ADH genes affect interpretation of ADH1C association studies?

Significant linkage disequilibrium (LD) exists in the region of the gene cluster composed of ADH6, ADH1A, ADH1B, ADH1C, and ADH7 genes, which complicates the interpretation of association studies . ADH1C is in a different haplotype block from ADH1B (multiallelic D' = 0.99 for ADH1C block; multiallelic D' = 0.6 for ADH1B), despite their physical proximity on chromosome 4q .

When conducting association studies, researchers should investigate polymorphisms that are in the same haplotype block with ADH1C (including nonsynonymous SNPs) or polymorphisms on nearby genes within this strong LD structure . Without accounting for this LD structure, studies may mistakenly attribute effects to ADH1C that are actually due to variants in nearby genes or to haplotype effects.

Haplotype construction, counting, and LD block definition should be performed using genotypes from relevant population samples (e.g., European and Asian samples from HapMap) to properly assess LD patterns specific to the study population .

What are the proposed mechanisms by which ADH1C variants influence alcohol dependence risk?

The primary hypothesized mechanism is that the highly active ADH1C 350Ile (ADH1C*1) variant increases acetaldehyde levels following alcohol consumption . Elevated acetaldehyde produces negative physiological reactions to alcohol (including flushing, nausea, and tachycardia), which may reduce alcohol consumption and consequently decrease the likelihood of developing alcohol dependence .

This protective mechanism is similar to that observed with other alcohol metabolism genes such as ADH1B and ALDH2. Individuals with genotypes that result in rapid alcohol metabolism to acetaldehyde but slower acetaldehyde metabolism (e.g., carriers of ADH1C1 and/or ALDH22) experience higher acetaldehyde levels after drinking, leading to adverse reactions that discourage continued alcohol consumption .

Conversely, carriers of ADH1C*2 (350Val) alleles, which encode less active enzymes, may accumulate acetaldehyde more slowly after alcohol consumption, resulting in fewer negative effects and potentially higher risk for alcohol dependence .

How do ADH1C allele frequencies vary across different populations?

ADH1C allele frequencies show substantial variation across global populations:

  • Asian populations: Low frequency of the 350Val (ADH1C*2) allele, approximately 8% in controls and 14% in patients with alcohol dependence. The frequency varies from 0% to 20% in controls and 0% to 32% in patients .

  • European populations: Much higher frequency of the 350Val allele, averaging 45% in both controls (range 24%-59%) and patients (range 30%-62%) .

  • Mexican populations: Intermediate frequency of approximately 35% in both controls (range 34%-38%) and patients (range 32%-39%) .

  • African populations: Lower frequency compared to Europeans, with the 350Val allele present in 13% of controls (range 12%-13%) and 16% of patients (range 13%-17%) .

The ADH1C1 (350Ile) allele prevalence ranges from 40% in Polish populations to nearly 100% in some Chinese aboriginal populations such as the Ami . In Vietnamese populations, the frequency of the ADH1C2 allele is approximately 8.3%, with the ADH1C*1 allele being eleven times more prevalent (91.7%) .

What patterns of association between ADH1C variants and alcohol dependence are observed across different ethnic groups?

The association between ADH1C variants and alcohol dependence shows striking ethnic differences:

  • Asian populations demonstrate the strongest and most consistent association between ADH1C variants and alcohol dependence. Among 30 Asian studies, 26 showed higher 350Val frequency in cases than in controls, with an allelic P value of 4×10^-33 and odds ratio of 2.14 (95% CI: 1.89-2.43), indicating a strong protective effect of the 350Ile allele against alcohol dependence .

  • European populations show less consistent associations. Of 17 European studies, 10 showed higher frequency of the 350Val allele in cases, 2 showed equal frequencies, and 5 did not follow this pattern .

  • All studies of African Americans showed higher frequency of the 350Val allele in cases than in controls .

  • Two of three studies of Mexican Americans showed higher frequency of the 350Val allele in cases .

How should researchers account for population stratification in ADH1C studies?

Researchers should implement several strategies to address population stratification in ADH1C studies:

  • Separate analyses by ethnic group: Given the significant differences in allele frequencies and effect sizes across populations, stratified analyses by ethnic background are essential for accurate interpretation .

  • Match cases and controls: Careful matching of cases and controls within the same ethnic populations helps minimize confounding due to population stratification .

  • Genomic control methods: When performing large-scale association studies, researchers should employ genomic control methods using ancestry-informative markers to detect and correct for population stratification.

  • Hardy-Weinberg equilibrium testing: Verify that allele and genotype frequencies within each population do not deviate from Hardy-Weinberg equilibrium (p>0.050), as significant deviations may indicate population stratification or genotyping errors .

  • Meta-regression techniques: When combining data across populations, employ meta-regression techniques to formally test for differences in effect sizes between ethnic groups .

Beyond alcohol dependence, what other clinical conditions are associated with ADH1C polymorphisms?

ADH1C polymorphisms have been associated with several alcohol-related medical conditions beyond alcohol dependence:

  • Alcohol-related liver disease: Studies suggest ADH1C variants influence susceptibility to alcoholic liver disease, with the ADH1C*1 (350Ile) allele potentially offering protection against liver damage in heavy drinkers .

  • Cirrhosis: ADH1C polymorphisms are associated with altered risk for alcohol-induced cirrhosis, though the strength of association varies across populations .

  • Pancreatitis: Evidence suggests ADH1C variants may influence risk for alcohol-related pancreatitis, with genotype affecting the rate of alcoholic pancreatitis development in chronic drinkers .

These associations likely relate to differences in acetaldehyde production and clearance, as acetaldehyde is toxic to tissues and its accumulation may contribute to organ damage. The specific mechanisms linking ADH1C variants to these conditions warrant further investigation through experimental models and clinical studies .

How do ADH1C polymorphisms interact with other alcohol metabolism genes like ADH1B and ALDH2?

The interaction between ADH1C, ADH1B, and ALDH2 polymorphisms creates a complex genetic landscape affecting alcohol metabolism and dependence risk:

  • ADH1B and ADH1C interaction: These genes are physically close and functionally related, though they reside in different haplotype blocks. Their combined effects on alcohol metabolism can be additive or synergistic, with the protective effect of ADH1B2 typically stronger than that of ADH1C1 .

  • ADH1C and ALDH2 interaction: Carriers of both ADH1C1 (highly active) and ALDH22 (inactive) experience particularly high acetaldehyde levels after alcohol consumption, potentially providing enhanced protection against heavy drinking .

  • Combined genotype effects: A large meta-analysis showed that carriers of ADH1B1 and ADH1C2 alleles (less active alcohol dehydrogenases) combined with the highly active ALDH2*1 allele have increased risk of alcoholism, likely reflecting reduced acetaldehyde accumulation in these individuals .

  • Gene-environment interactions: Environmental factors (e.g., cultural drinking norms) may modify genetic effects, particularly where the prevalence of protective alleles like ALDH2*2 is high .

What methodological challenges exist in translating ADH1C research into clinical applications?

Several methodological challenges complicate the translation of ADH1C research into clinical applications:

  • Diagnostic heterogeneity: Different studies employ varying diagnostic criteria (DSM-III-R, DSM-IV, ICD-10) for alcohol dependence, with varying levels of stringency that affect case selection and potentially effect sizes .

  • Recruitment strategy variations: Clinical treatment samples versus general population samples may yield different results due to severity differences in alcohol dependence presentations .

  • Sex differences: Studies using only males or females may produce different results than mixed-sex samples, particularly without appropriate sex matching between cases and controls .

  • Developmental trajectories: The genetic effects of ADH1C variants may change over the lifetime of alcohol use—functioning as a protective factor at one stage but becoming neutral or even a risk factor at another stage .

  • Cultural and environmental influences: Cultural differences in alcohol consumption patterns can interact with genetic effects, confounding interpretation across diverse populations .

  • Low prevalence of certain genotypes: The low prevalence of Val350Val individuals in some Asian populations makes it difficult to determine the effect of homozygous individuals without very large samples .

What experimental designs are most effective for studying ADH1C function?

Optimal experimental designs for studying ADH1C function include:

  • In vitro enzyme kinetics: Recombinant expression of different ADH1C variants allows direct measurement of enzymatic activity (Vmax, Km) under controlled conditions, enabling precise quantification of functional differences between variants .

  • Cell-based models: Hepatocyte cell lines expressing different ADH1C variants can assess the impact on cellular ethanol metabolism, acetaldehyde production, and resulting cellular responses.

  • Transgenic animal models: Humanized mice expressing different ADH1C variants can provide insights into whole-organism effects on alcohol metabolism, preference, and toxicity.

  • Pharmacogenetic challenge studies: Human participants with known ADH1C genotypes can undergo alcohol challenge tests with measurement of blood acetaldehyde levels, physiological responses, and subjective experiences to directly assess genotype-phenotype relationships .

  • Longitudinal studies: Following individuals with different ADH1C genotypes over time can reveal how genetic effects may change across developmental stages and drinking trajectories .

How should researchers control for potential confounding factors in ADH1C association studies?

To control for potential confounding factors in ADH1C association studies, researchers should:

  • Match cases and controls: Careful matching for age, sex, ethnicity, and other relevant demographic factors reduces confounding .

  • Adjust for co-occurring conditions: Statistical adjustment for comorbid psychiatric conditions and substance use disorders that may affect alcohol consumption patterns.

  • Consider linkage disequilibrium: Account for LD with nearby genes, particularly ADH1B, by genotyping and controlling for known functional variants in these genes .

  • Assess environmental factors: Measure and adjust for environmental influences on drinking behavior, including cultural factors, socioeconomic status, and exposure to drinking environments .

  • Use stringent phenotyping: Employ standardized diagnostic criteria with clearly defined phenotypes, potentially focusing on specific aspects of alcohol dependence such as tolerance or withdrawal symptoms .

  • Set appropriate age thresholds for controls: Use older control samples that can be more accurately categorized, as younger individuals may not have fully transited the age of risk for alcohol dependence .

What are the recommended approaches for genotyping ADH1C variants in diverse populations?

For effective genotyping of ADH1C variants across diverse populations, researchers should:

  • Select appropriate genotyping platforms: Use methods with high accuracy for the specific variants being studied, such as TaqMan assays, sequencing, or SNP arrays.

  • Include positive and negative controls: Incorporate samples of known genotype as controls in each genotyping batch to verify accuracy.

  • Perform duplicate genotyping: Re-genotype a subset of samples (5-10%) to calculate error rates and ensure reliability.

  • Test for Hardy-Weinberg equilibrium: Verify that genotype frequencies in control groups do not deviate from Hardy-Weinberg expectations, which could indicate genotyping errors or population stratification .

  • Consider haplotype analysis: In addition to individual SNPs, analyze haplotypes across the ADH gene cluster to capture extended genetic variation patterns .

  • Sequence verification: For novel or rare variants, confirm genotypes through direct sequencing.

  • Population-specific variant selection: Consider known variation patterns in the target population when selecting variants to genotype, as some polymorphisms may be rare or absent in certain populations .

Product Science Overview

Structure and Function

ADH1C is a protein-coding gene that produces a single polypeptide chain containing 399 amino acids, with a molecular mass of approximately 42.4 kDa . The enzyme is characterized by its high activity for ethanol oxidation, converting ethanol to acetaldehyde, which is a key step in ethanol catabolism . This process is essential for the body’s ability to metabolize and eliminate alcohol.

The enzyme exists as several homo- and heterodimers of alpha, beta, and gamma subunits. The gamma subunit, encoded by the ADH1C gene, is one of these subunits and is known for its high activity in ethanol oxidation . The genes encoding the alpha, beta, and gamma subunits are organized in a genomic segment as a gene cluster .

Recombinant Production

Human recombinant ADH1C is produced using Escherichia coli (E. coli) expression systems. The recombinant enzyme is typically fused to a His-tag at the N-terminus to facilitate purification through chromatographic techniques . This recombinant form is used in various research and industrial applications to study the enzyme’s properties and its role in alcohol metabolism.

Clinical and Research Significance

ADH1C has been studied extensively for its role in alcohol metabolism and its association with alcohol dependence and other diseases. While an association between ADH1C polymorphism and alcohol dependence has not been firmly established, the enzyme’s activity in ethanol oxidation makes it a significant focus of research in understanding alcohol-related disorders .

Additionally, ADH1C is involved in other metabolic pathways, such as the oxidation of retinol and the metabolism of retinoic acid, which are important for various physiological processes . The enzyme’s role in these pathways highlights its broader significance beyond alcohol metabolism.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.